InvestorsHub Logo
Followers 79
Posts 24450
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Monday, 04/16/2018 9:26:46 AM

Monday, April 16, 2018 9:26:46 AM

Post# of 27354
TROV - .3621 Pre-market now at .3803/.385

Trovagene Presents Data at AACR Meeting 2018 Showing Synergy of PCM-075 in Combination with FLT3 Inhibitors in Acute Myeloid Leukemia (AML)



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.